Placebo Comparator (0.9% NaCl)

DRUG3 trials

Sponsors

Huazhong University of Science and Technology, Marc Donath, Ruijin Hospital

Conditions

End-stage Renal Disease (ESRD)Frontotemporal DementiaGastrectomyGastric Bypass SurgeryGlucose Metabolism DisordersInflammationNondepolarising Muscle RelaxantsPostprandial Hypoglycemia

Phase 1

MSC-Exosome Therapy for Frontotemporal Dementia

Not yet recruitingNCT07638813

Ruijin HospitalFrontotemporal Dementia

Start: 2026-07-01End: 2027-10-31Target: 33Updated: 2026-07-13

Phase 2

Anakinra for the Treatment of Postprandial Hypoglycemia in a Patient With Total Gastrectomy and End-Stage Renal Disease

Not yet recruitingNCT07580079

Marc DonathEnd-stage Renal Disease (ESRD), Gastrectomy, Gastric Bypass Surgery +3

Start: 2026-07-01End: 2026-12-01Target: 1Updated: 2026-05-12

Unknown Phase

Effect of Ulinastatin on the Action of NDMRs (Rocuronium / Cisatracurium)

CompletedNCT05716256

Huazhong University of Science and TechnologyNondepolarising Muscle Relaxants

Start: 2023-02-15End: 2023-06-25Updated: 2026-07-08